EDUCATION

1966-1970 University of California, Irvine, M.D. Degree

1971-1974 University of California, Irvine, Psychiatry Residency

1973-1974 Los Angeles Group Psychoanalytic Institute, Training

1979-1984 Southern California Psychoanalytic Institute, Ph.D.

BOARD CERTIFICATION

1976 Diplomat of the American Board of Psychiatry and Neurology

1995 Certified in Geriatric Psychiatry by the American Board of Psychiatry and Neurology

PROFESSIONAL EXPERIENCE

1974-Present: Private Practice of General Psychiatry

1974-1975: Outpatient Clinic-Family Therapy Coordinator, Long Beach Veterans Hospital

1974-1976: Consultation Liaison Service,UC Irvine Medical Center

1976-1977: Chief of Consultation Liaison Service, UC Irvine Medical Center

1977-1979: Chief of Inpatient Psychiatric Services, Long Beach Veterans Hospital

1983-1984: Council Member, Orange County Psychiatric Society

1983-1986: Outpatient Clinic, Long Beach Veterans Hospital

1975-Present: Associate Medical Director, Pharmacology Research Institute, Newport Beach, CA

1986-1988: Medical Director, Mental Health Unit, Hoag Memorial Hospital Presbyterian

1986-1989: Consulting Staff Psychiatrist, Student Health Service, UC Irvine

1988-1993: Chief Psychiatric Consultant, CardiacTransplantation Team, Hoag Memorial Hospital Presbyterian

1988-1996: Chief Psychiatric Consultant to Sleep Center, Hoag Memorial Hospital Presbyterian

1988-1989: Medical Director, Adult Psychiatry Program, Laguna Hills Hospital

1989-Present: Physician's Assistance Committee, Hoag Memorial Hospital (Responsible, in 1989, for starting and serving as first Chair of Committee)

1990-1991: Medical Director, Partial Hospitalization Program, Laguna Hills Hospital

1992-1996: Chief of Psychiatric Division, Hoag Memorial Hospital Presbyterian

ACADEMIC APPOINTMENTS

Associate Clinical Professor
Department of Psychiatry and Human Behavior
University of California, Irvine
1974 to 2007

TEACHING APPOINTMENTS GENERAL

In above cited positions at UC Irvine Medical Center and Long Beach VA Hospital at least half my time was devoted to teaching.

1974-2004: Supervision of Residents in Individual, Family, and Group Psychotherapy and Psychopharmacology.

1974-1977: Coordinator and lecturer for seminar series in Group and Family Therapy for both medical students and residents at UC Irvine Medical Center.

1975-1979: Co-taught, with a UCI Professor of Literature, a seminar for graduate and post-graduate students in which novels and other literature were read from a psychoanalytic point of view.

1976-1977: Coordinator and lecturer for two separate seminar series for UC Irvine psychiatric residents on the topics of Psychosomatic Medicine and Psychoses.

1978-1984: Clinical Staff Rounds at Long Beach Veterans Hospital. (Patient interview before Residents and Staff, 1-3 times weekly.) During same period supervised residents in Individual, Group and Family Therapy. (Including live supervision of group therapy.)

1984-Present: Southern California Psychoanalytic Institute, Faculty Member.

1985-1987: Courses on Psychopharmacology for Ph.D. Candidates at California Graduate Institute and United States International University.

1985-1993: Lecturer in Core Curriculum on Psychoanalysis in UC Irvine Residency program.

RESEARCH EXPERIENCE

I have worked with the Pharmacology Research Institute (PRI) since its inception in 1975 and have been Associate Medical Director since 1983.

At PRI we have conducted about 700 scientific research studies on medication effectiveness, covering a wide range of psychiatric and some neurological disorders such as migraine headaches and dementia.

We have conducted most of our studies on Major Depression and other mood disorders such as Bipolar Disorders, Dysthymia. We have also studied anxiety states including Generalized Anxiety, Panic Disorders, Post-traumatic Stress Disorders and Social Phobias. In addition to studying virtually all the major psychiatric disorders, including ADHD, Schizophrenia, Adjustment Disorders, and Sleep Disorders, we have studied other parameters such as alcohol response and alcohol interaction with other drugs, placebo response, and medication side effects. We have always conducted geriatric psychiatry studies, but the last few years our focus has intensified toward senile memory loss and dementia studies. Since mid-1995 we have also conducted many Migraine Headache and Smoking Cessation Studies.

PROFESSIONAL APPOINTMENTS AND MEMBERSHIP

American Medical Association

International Psychoanalytic Association

American Psychoanalytic Association

New Center for Psychoanalysis

Appointed Life Fellow, American Psychiatric Association, 1987

ABSTRACTS AND ORAL PRESENTATIONS

1. Wilcox, C.S.; Cohn, J.B.; Katz, B.B.; Mijares, C.P.; De Francisco, D.F.; Heiser, J.F.; and Linden, R.D. A Placebo-Controlled Study of Two Arylpiperazines in Outpatients with Generalized Anxiety Disorder (GAD). 31st Anual Meeting, American College of Neuro-psychopharmacology, San Juan, Puerto Rico, December 15, 1992.

2. Wilcox, C.S.; Heiser, J.F.; Cohn, J.B.; Dale, J.L.; Linden, R.D.; Katz, B.B.; Morrisey, J.L.; and, De Francisco, D.F. "Placebo Response in G.A.D. Trials: An Analysis of Purported Predictors", 32nd Annual Meeting, American College of Neuropsychopharmacology, Honolulu, Hawaii, December 14, 1993.

3. De Francisco, D. “Forensic Implications of Psychoanalytic Observation on Post Traumatic Stress Disorder.” Paper presented at the annual meeting of the American College of Forensic Examiners, 1996.

4. De Francisco, Don. "Stranger Anxiety in Traumatic Stress." Paper presented at the 5th annual meeting, European Conference on Traumatic Stress, Maastricht, The Netherlands, July 1997.

5. Wilcox, C.S.; Morrissey, J.L.; Heiser, J.F.; Katz, B.B.; Schneider, A.L.; Bacon, P.F. and De Francisco, D. F. “Protocol Design and Predictors of Placebo Response: Studies with Antidepressants and Anxiolytics,” 36th Annual Meeting, American College of Neuropsychopharmacology, Kamuela, Hawaii, December 10. 1997.

6. Wilcox, C.S.; Morrissey, J.; Heiser, J.F.; Katz, B.B.; Cho, F.; Grosz, D.; Linden, R.D.; and De Francisco, D.F. “Patients' Motivations as Potential Predictors of Placebo Response: Yesterday and Today.” 37th Annual Meeting, American College of Neuro-psychopharmacology, Loas Croabas, Puerto Rico, December 14, 1998.

7. Wilcox, C.S.; Cho, F.E.; Heiser, J.F.; Morrissey, J.L.; Katz, B.B.; Grosz, D.E.; and De Francisco, D.F. “Placebo Response in Depression Studies: Do Previously Reported Predictors Have any Utility?” 39th Annual N.C.D.E.U. Meeting, Boca Raton, Florida, June 2, 1999.

PUBLICATIONS

1. De Francisco, D.F. and Watson, D. "Uncertain Certainty--Acute Leukemia." The Experience of Dying. Chapter 24. Edited by E. Mansell Pattison. Reinhardt & Winston, 1975.

2. Pattison, E. M.; De Francisco, D.F.; Frazier, H.; Wood, P.E.; and Crowder, J. "A Psychosocial Kinship Model for Family Therapy." The American Journal of Psychiatry. Vol. 131:12, December 1975.

3. Heiser, J. F. and De Francisco, D.F. "The Treatment of Pathological Panic States with Propranolol." American Journal of Psychiatry, 1976, Vol. 133, pp. 1390-1394.

4. De Francisco, D.; Anderson, D.; Pantano, R.; and Kline, F. "Length of Hospital Stay vs. Rapid Readmission." Hospital and Community Psychiatry, 1980, Vol. 31, No. 3, pp. 196-197.

5. De Francisco, D. "The Child Dream and the Child Transference." The Journal of the American Psychoanalytic Association, 1986, Vol. 34, No. 1, pp. 93-121.

6. De Francisco, D. "Kohut's Enhancement of Classical Psychoanalysis." Psychiatric Annals, August 1986.

7. Wilcox, C.S.; Cohn, J.B.; Linden, J.; Heiser, J.; Lucas, P.B.; Morgan, D.; and De Francisco, D. "Predictors of Placebo Response: A Retrospective Analysis." Psychopaharmacology Bulletin, 1992, Vol. 28, No. 2, pp. 157-162.

8. Wilcox, C.S.; Ryan, P.J.; Morrisey, J.L.; Cohn, J.B.; De Francisco, D.F.; Linden, R.D.; and Heiser, J.F. "A Fixed-Dose Study of Adinazolam-SR Tablets in Generalized Anxiety Disorder." Prog. Neuro-Psychopharmacol. &Biol. Psychiat., 1994, Vol. 18, pp. 979-993.

9. Wilcox, C.S.; Cohn, J.B.; Katz, B.B.; Guarino, J.J.; and De Francisco, D. "Short- and Long-Term Placebo and Active-Controlled Studies of Mianserin in Outpatients with Major Depression." International Clinical Psychopharmacology, 1994 Vol 8, No 4, pp. 271-279.

10. Wilcox, C.S.; Katz, B.B.; Morgan, D.L.; Morrissey, J.L.; Schneider, A.L.; and De Francisco, D. "Increasing Ethnic Diversity and Managed Care: How Will They Influence Research Patient Recruitment in the 1990’s?" Psychopharmacology Bulletin, 1996, Vol. 32, pp. 193-200.

11. De Francisco, D.F. A Physician’s Experience as Both a Researcher and a Clinician [Invited Paper, Special Report Issues] Psychiatric Times, XVII (6): 57-60, June 2000

12. De Francisco, Don. “The Greater the Artistry, the Greater the Danger,” Violence in the Media: A Symposium, American Journal of Forensic Psychiatry, 2000, Vol. 21, No. 4, pp. 27-29.

13. De Francisco, Don. “In the Long Run, We Are All Dead,” Response to an Article by Jack Kevorkian, Solve the Organ Shortage: Let the Bidding Begin, American Journal of Forensic Psychiatry, 2001, Vol. 22, No. 2, pp. 52-57.

14. Wilcox, C.S.; Linden, R.D.; D’Amico, M.F.; De Francisco, D.F.; Morrissey, J.L. and Heiser, J.F. “Nefazodone in the Treatment of Elderly Patients with Depression”, Today’s Therapeutic Trends, 20(2): 183-196, 2002.

15. Gottschalk, L.; De Francisco, D.; Bechtel, R. “Computerized Content Analysis of Some Adolescent Letters of Napoleon Bonaparte: A Test of the Validity of the Method", Journal of Nervous and Mental Diseases, 2002, Vol. 190, No. 8